keyboard_arrow_up

Premenstrual Dysphoric Disorder (PMDD) Pipeline Review and Market Research, H1 2015

RnRMarketResearch.com adds ‘Premenstrual Dysphoric Disorder (PMDD) - Pipeline Review, H1 2015’ to its store. This report Pipeline Review, H1 2015', provides an overview of the Premenstrual Dysphoric Disorder (PMDD)'s therapeutic pipeline.

Premenstrual Dysphoric Disorder (PMDD) - Pipeline Review, H1 2015 report provides comprehensive information on the therapeutic development for Premenstrual Dysphoric Disorder (PMDD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Premenstrual Dysphoric Disorder (PMDD) and special features on late-stage and discontinued projects.

Get a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=395757 . (This is a premium report price at US$2000 for a single user PDF license)

Scope

- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in the therapeutics development for Premenstrual Dysphoric Disorder (PMDD) and enlists all their major and minor projects

- The report summarizes all the dormant and discontinued pipeline projects

- A review of the Premenstrual Dysphoric Disorder (PMDD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- A detailed assessment of monotherapy and combination therapy pipeline projects

Table of Contents:

Premenstrual Dysphoric Disorder (PMDD) Overview 6
Therapeutics Development 7
Pipeline Products for Premenstrual Dysphoric Disorder (PMDD) - Overview 7
Pipeline Products for Premenstrual Dysphoric Disorder (PMDD) - Comparative Analysis 8
Premenstrual Dysphoric Disorder (PMDD) - Therapeutics under Development by Companies 9
Premenstrual Dysphoric Disorder (PMDD) - Pipeline Products Glance 10
Clinical Stage Products 10
Early Stage Products 11

 The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.